China Life Sciences and Health Industry Client Briefing – September 2012 (October 4, 2012)


In This Issue:

• Merck-Simcere Joint Venture Starts Business in Pudong (Shanghai Daily 2012-09-13) – September 14, 2012

• Pfizer Joint Venture Set to Hire 600 Staff (Bloomberg News 2012-09-14) – September 14, 2012

• Biotec IPO Approved (Agencies 2012-09-07) – September 7, 2012

• SFDA: ID Cards to be Shown When Purchasing Cold Medicines Containing Ephedrine (Caijing 2012-08-31) – September 3, 2012

• NDRC Adjusts Retail Price Caps of Some Medicines (China News Service 2012-09-19) – September 19, 2012

• Antitrust Investigation of Guangzhou Pharmaceutical Company Limited’s Merger with Guangzhou Baiyunshan Pharmaceutical Co., Ltd. Completed (Caixin Media 2012-09-20) – September 21, 2012

• Circular from the Medical Reform Office under the State Council Expected to Make M&As of Drug Distributors Easier in China (Economic Information Daily 2012-09-17) – September 17, 2012

• Alliance Boots Says to Buy $91 Million Stake in China Pharma Retailer (Reuters 2012-09-16) – September 17, 2012

• Dutch Health Store Chain Opens First China Shop (China Daily 2012-09-24) – September 25, 2012

• Health Care System to Get 400b Yuan Injection, including prevention and control of chronic disease (China Daily 2012-09-04) – September 3, 2012

• China to Strengthen Urban-Rural Medical Co-op (Xinhua News Agency 2012-09-25) – September 25, 2012

• China Encourages Private Investment in Hospitals: Minister (CNTV 2012-09-17) – September 18, 2012

• Beijing Policies Encourage Development of Private Hospitals (China Daily 2012-08-31) – September 3, 2012

• Court Case Reveals Medical Companies Using Gutter Oil (Shanghai Daily 2012-09-03) – September 3, 2012

Please see full Alert below for more information.

LOADING PDF: If there are any problems, click here to download the file.

Written by:


Reed Smith on:

Popular Topics
Reporters on Deadline

"My best business intelligence, in one easy email…"

Your first step to building a free, personalized, morning email brief covering pertinent authors and topics on JD Supra:

Sign up to create your digest using LinkedIn*

*By using the service, you signify your acceptance of JD Supra's Privacy Policy.

Already signed up? Log in here

*With LinkedIn, you don't need to create a separate login to manage your free JD Supra account, and we can make suggestions based on your needs and interests. We will not post anything on LinkedIn in your name. Or, sign up using your email address.